557 — China Tian Yuan Healthcare Cashflow Statement
0.000.00%
- HK$319.18m
- HK$314.34m
- HK$26.85m
Annual cashflow statement for China Tian Yuan Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -126 | -19.1 | -40.3 | -28.8 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 66.9 | -11.7 | 2.45 | 0.199 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 90.4 | 35.2 | -1.99 | 24.6 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 52.6 | 16.3 | -30.4 | 5.1 | — |
Capital Expenditures | -0.336 | -1.46 | -1.35 | -0.595 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -10.9 | 0.042 | 0.115 | 0.959 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -11.2 | -1.42 | -1.23 | 0.364 | — |
Financing Cash Flow Items | -2.54 | -4.49 | -3.96 | -3.54 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.58 | -7.22 | -12.5 | -8.77 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 35.8 | 7.52 | -39.2 | -5.62 | — |